Editas Medicine, Inc. (0IFK.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 182.82M |
| Enterprise Value | 112.88M |
| P/E Ratio | -3.54 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 8.65 |
| Price/Book Ratio | 3 |
| Enterprise/Revenue | 5.11 |
| Enterprise/EBITDA | -3.42 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -1.57 |
| Operating Margin | -1.75 |
AD
Management Effectiveness
| Return On Assets | -0.31 |
| Return On Equity | -1.97 |
Income Statement
| Revenue | 40.52M |
| Revenue/Share | 0.39 |
| Gross Profit | 35.24M |
| EBITDA | -94.06M |
| Net Income | -160.06M |
| Diluted EPS | -1.8 |
Balance Sheet
| Total Cash | 211.65M |
| Total Cash/Share | 1.77 |
| Total Debt | 71.25M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 3.19 |
| Book Value Per Share | 0.88 |
Price History
| 52-Week Change | -3.28 |
| 52-Week High | 11.79 |
| 52-Week Low | 2.62 |
| Moving Average 50 Days | 8.49 |
| Moving Average 200 Days | 8.69 |
Statistics
| Average Volume | 5,909 |
| Shares Outstanding | 92.35M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
